This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Utah Research Foundation, Technion Research & Development Foundation Ltd, Ballard Spahr LLP. Active years: 2020-2023.
Company Filing History:
3 out of 1,685 
2 out of 1,003 
1 out of 1 Years Active: 2020-2023
Title: The Innovative Contributions of Joshua Schiffman
Introduction
Joshua Schiffman is a prominent inventor based in Salt Lake City, UT. He has made significant contributions to the field of cancer research and treatment, holding a total of 4 patents. His work focuses on innovative methods and compositions aimed at preventing and treating cancer, showcasing his dedication to advancing medical science.
Latest Patents
Schiffman's latest patents include groundbreaking methods for inhibiting cancer cells using nucleic acid sequences that encode elephant p53 or its amino acid sequences. This innovative approach aims to provide new avenues for cancer treatment. Additionally, he has developed patents related to Neonatal NET-inhibitory Factor (nNIF) and nNIF-Related Peptides (NRPs). These patents offer methods for treating and preventing inflammatory disorders and cancer, as well as inhibiting metastasis in patients diagnosed with cancer. The administration of nNIF and/or NRPs to patients at risk of developing these conditions represents a significant advancement in therapeutic strategies.
Career Highlights
Joshua Schiffman has worked with esteemed organizations such as the University of Utah Research Foundation and Technion Research & Development Foundation Ltd. His career reflects a commitment to research and innovation in the medical field, particularly in oncology.
Collaborations
Throughout his career, Schiffman has collaborated with notable colleagues, including Avi Schroeder and Lisa Abegglen. These partnerships have contributed to the development of his innovative research and patents.
Conclusion
Joshua Schiffman's work exemplifies the impact of innovation in cancer research and treatment. His patents and collaborations highlight his commitment to improving patient outcomes through scientific advancements. His contributions continue to inspire future research in the field.